https://newzino.com/story/ai-chip-custom-silicon-nvidia-selloff Newzino en 2026-07-28T15:09:44+00:00 Global chip selloff wipes out over $1 trillion as custom AI silicon challenges Nvidia https://newzino.com/story/ups-2026-freight-demand-recovery Newzino en 2026-07-28T11:17:18+00:00 UPS shrinks its Amazon business to chase profit https://newzino.com/story/nyc-gig-driver-just-cause-protections Newzino en 2026-07-28T11:14:53+00:00 New York City tries to end at-will deactivation for app drivers https://newzino.com/story/syngap1-first-disease-modifying-therapy Newzino en 2026-07-28T03:09:24+00:00 First treatment for SYNGAP1 genetic disorder enters human testing https://newzino.com/story/autonomous-vehicle-safety Newzino en 2026-07-27T21:52:36+00:00 Driverless cars face the safety test https://newzino.com/story/trump-federal-voter-list-litigation Newzino en 2026-07-27T18:06:21+00:00 Court fight over Trump's federal voter list https://newzino.com/story/us-missile-defense-launch-capacity Newzino en 2026-07-27T15:09:49+00:00 America expands its missile-defense launch capacity https://newzino.com/story/alzheimers-microglia-resilience-target Newzino en 2026-07-27T03:09:07+00:00 Scientists map an immune-cell 'tipping point' that may decide who develops Alzheimer's dementia https://newzino.com/story/sudan-civil-war-kordofan-offensive Newzino en 2026-07-27T03:05:45+00:00 Sudan's army breaks RSF siege of El Obeid and secures the export highway https://newzino.com/story/crispr-cas13-immune-cold-cancer Newzino en 2026-07-26T18:07:29+00:00 CRISPR tool makes 'immune-cold' prostate cancer respond to immunotherapy in mice